These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35343668)

  • 1. Triglyceride-Glucose Index and Hepatic Steatosis Index for the assessment of liver steatosis in HCV patients.
    Preveden T; Veres B; Ruzic M; Pete M; Bogic S; Kovacevic N; Procopio AC; Fagoonee S; Luzza F; Abenavoli L
    Minerva Gastroenterol (Torino); 2023 Jun; 69(2):254-260. PubMed ID: 35343668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Sterling RK; King WC; Khalili M; Kleiner DE; Hinerman AS; Sulkowski M; Chung RT; Jain MK; Lisker-Melman MA; Wong DK; Ghany MG;
    Dig Dis Sci; 2022 Feb; 67(2):676-688. PubMed ID: 33559089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.
    Simental-Mendía LE; Simental-Mendía E; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Ann Hepatol; 2016; 15(5):715-20. PubMed ID: 27493110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children.
    Shi M; Liu P; Li J; Su Y; Zhou X; Wu C; Chen X; Zheng C
    J Diabetes; 2021 Sep; 13(9):744-753. PubMed ID: 33576570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.
    Wang M; Chang M; Shen P; Wei W; Li H; Shen G
    Lipids Health Dis; 2023 Nov; 22(1):186. PubMed ID: 37924128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
    Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
    Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1.
    Petta S; Di Marco V; Di Stefano R; Cabibi D; Cammà C; Marchesini G; Craxì A
    J Viral Hepat; 2011 Jul; 18(7):e372-80. PubMed ID: 21692950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.
    Busca C; Sánchez-Conde M; Rico M; Rosas M; Valencia E; Moreno A; Moreno V; Martín-Carbonero L; Moreno S; Pérez-Valero I; Bernardino JI; Arribas JR; González J; Olveira A; Castillo P; Abadía M; Guerra L; Mendez C; Montes ML
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac279. PubMed ID: 35873289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience.
    Scicali R; Di Pino A; Urbano F; Ferrara V; Marchisello S; Di Mauro S; Scamporrino A; Filippello A; Rabuazzo AM; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):869-879. PubMed ID: 33549441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity.
    Simental-Mendía LE; Ortega-Pacheco CJ; García-Guerrero E; Sicsik-Aragón MA; Guerrero-Romero F; Martínez-Aguilar G
    Eur J Pediatr; 2021 Jun; 180(6):1755-1760. PubMed ID: 33492440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy.
    Chang JW; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SU
    Gut Liver; 2021 Jan; 15(1):117-127. PubMed ID: 32066210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
    BMC Infect Dis; 2017 May; 17(1):361. PubMed ID: 28535787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease.
    Huang Q; Tan X; Wu Q; Zhao H; Chen H; Yu X; Wang J; Huang X; Huang Y; Wei J; Wu F; Zhu H; Wang L
    Biomark Med; 2024 Feb; 18(3):123-135. PubMed ID: 38456353
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
    Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.